Ptc Therapeutics (PTCT) Amortization - Intangibles (2017 - 2026)

Ptc Therapeutics' Amortization - Intangibles history runs 10 years deep, the most recent figure standing at $11.6 million for Q1 2026.

• On a quarterly basis, Amortization - Intangibles rose 204.92% year-over-year to $11.6 million in Q1 2026; TTM through Mar 2026 was $32.5 million, a 150.08% increase from a year earlier, with the FY2025 full-year figure at $24.7 million, down 59.26% from the prior year.
• Amortization - Intangibles climbed to $11.6 million in Q1 2026 per PTCT's latest filing, from $9.3 million in the prior quarter.
• Across five years, Amortization - Intangibles topped out at $77.2 million in Q4 2023 and bottomed at $2.9 million in Q2 2024.
• The 5-year median for Amortization - Intangibles is $23.5 million (2022), against an average of $25.7 million.
• Across the five-year window, Amortization - Intangibles plunged 95.71% in 2024 and surged 204.92% in 2026, its largest moves.
• Year by year, Amortization - Intangibles stood at $35.8 million in 2022, then jumped by 115.79% to $77.2 million in 2023, then plunged by 95.71% to $3.3 million in 2024, then surged by 182.7% to $9.3 million in 2025, then grew by 23.87% to $11.6 million in 2026.
• Per Business Quant, the three latest PTCT Amortization - Intangibles figures stand at $11.6 million (Q1 2026), $9.3 million (Q4 2025), and $7.5 million (Q3 2025).